exclusivity

The Top Line
Podcast

A closer look at pharma’s top patent losses in 2025

This week on "The Top Line," we explore the potential impacts of this year's sizable patent cliff on the pharma industry at large.
clock time delay cancelled month year hour

The top 10 drugs losing US exclusivity in 2025

Mar 17, 2025 3:00am
Teva

Teva launches Revlimid generic, the first to do so in U.S.

Mar 7, 2022 11:11am
FDA

Catalyst one-ups Jacobus, FDA in Firdapse exclusivity appeal

Oct 1, 2021 12:11pm
Wooden gavel and gold legal scale that appear to have sunlight falling on them

Novartis sues FDA, claiming Sanofi's Aubagio isn't really new

Mar 11, 2021 11:34am
Gilead

Gilead tries—and fails—to bail out of HIV drug safety lawsuit

May 14, 2019 10:43am